Beyer B, Kühne K, Böhm K, Schiffmann J, Heinzer H, Michl U, Huland H, Graefen M, Haese A, Steuber T
Martini-Klinik Hamburg, Martinistraße 52, 20246, Hamburg, Deutschland.
Urologe A. 2015 Jan;54(1):34-40. doi: 10.1007/s00120-014-3589-y.
Open radical retropubic prostatectomy (RRP) in obese patients (BMI ≥30) is associated with increased perioperative morbidity. The aim of the study was to evaluate the possible benefit of DaVinci robotic-assisted laparoscopic prostatectomy (RARP) compared to RRP in obese patients.
We identified 255 patients with a localized prostate cancer (PCa) and BMI ≥30 treated with radical prostatectomy from January 2009 to December 2011. To adjust for risk factors of increased perioperative morbidity (nerve-sparing, pelvic lymph node dissection, prostate volume), a propensity score-based matching was performed between RRP and RARP (n=115 each group). Both groups were compared by taking into consideration histopathological outcomes as well as peri- and postoperative (30 days) morbidity.
There were no differences in histopathological characteristics (pT/pN-stage, Gleason score, R-stage; all p>0.05) in both groups. Mean blood loss (276 ml vs. 937 ml), transfusion rate (0.9% vs. 8.7%) and 30-day complications according to the Clavien classification system (Clavien ≥ 2; 9.5% vs. 22.6%) were decreased in RARP (all p<0.05). In a multivariate logistic regression model, RARP vs. RRP was associated with a significantly reduced risk of a Clavien ≥ 2 complication during follow-up (OR 0.3; p= 0.0047). Recovery of continence was significantly better for RARP patients after 3 months (p= 0.02). There was no difference in erectile function 12 months postoperatively.
Our findings of decreased transfusion and complication rates and a trend of better early recovery of continence in RARP should be considered in obese patients (BMI >30) scheduled for radical prostatectomy.
肥胖患者(BMI≥30)行开放性耻骨后根治性前列腺切除术(RRP)会增加围手术期发病率。本研究旨在评估达芬奇机器人辅助腹腔镜前列腺切除术(RARP)相较于RRP用于肥胖患者可能带来的益处。
我们纳入了2009年1月至2011年12月期间接受根治性前列腺切除术治疗的255例局限性前列腺癌(PCa)且BMI≥30的患者。为校正围手术期发病率增加的危险因素(保留神经、盆腔淋巴结清扫、前列腺体积),在RRP组和RARP组(每组n = 115)之间进行了基于倾向评分的匹配。通过考虑组织病理学结果以及围手术期和术后(30天)发病率对两组进行比较。
两组的组织病理学特征(pT/pN分期、Gleason评分、R分期;所有p>0.05)无差异。RARP组的平均失血量(276 ml对937 ml)、输血率(0.9%对8.7%)以及根据Clavien分类系统的30天并发症发生率(Clavien≥2;9.5%对22.6%)均降低(所有p<0.05)。在多因素逻辑回归模型中,RARP组与RRP组相比,随访期间Clavien≥2并发症的风险显著降低(OR 0.3;p = 0.0047)。3个月后,RARP组患者的控尿恢复情况明显更好(p = 0.02)。术后12个月勃起功能无差异。
对于计划行根治性前列腺切除术的肥胖患者(BMI>30),应考虑我们关于RARP组输血和并发症发生率降低以及早期控尿恢复趋势更好的研究结果。